Advertisement

Symptoms and Their Correlates in Chronic Kidney Disease

  • Steven D. Weisbord
    Correspondence
    Address correspondence to Steven Weisbord, VA Pittsburgh Healthcare System, Mailstop 111F-U, 7E Room 120, Pittsburgh, PA 15240.
    Affiliations
    Renal Section, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA

    Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA.
    Search for articles by this author
      While there is a significant body of literature documenting the impairments in health-related quality of life (HRQOL) experienced by patients with end-stage renal disease (ESRD), recent work has helped to elucidate the mediators of impaired well-being in this patient group. Physical and emotional symptoms have been shown to be common, frequently severe, and directly linked with impaired HRQOL. The following review explores the process of symptom assessment in patients with chronic kidney disease (CKD), presents an overview of the composite burden and importance of symptoms in patients with ESRD, highlights particularly common and distressing symptoms for which existing treatment strategies may be applicable, and discusses future directions for efforts to address and alleviate symptoms in the growing population of patients who suffer from CKD.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Evans R.W.
        • Manninen D.L.
        • Garrison Jr, L.P.
        • et al.
        The quality of life of patients with end-stage renal disease.
        N Engl J Med. 1985; 312: 553-559
        • Johnson J.P.
        • McCauley C.R.
        • Copley J.B.
        The quality of life of hemodialysis and transplant patients.
        Kidney Int. 1982; 22: 286-291
        • Kimmel P.L.
        • Peterson R.A.
        • Weihs K.L.
        • et al.
        Aspects of quality of life in hemodialysis patients.
        J Am Soc Nephrol. 1995; 6: 1418-1426
        • Kimmel P.L.
        Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes.
        Am J Kidney Dis. 2000; 35: S132-S140
        • Kimmel P.L.
        • Patel S.S.
        Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with hemodialysis.
        Semin Nephrol. 2006; 26: 68-79
        • Kimmel P.L.
        • Peterson R.A.
        • Weihs K.L.
        • et al.
        Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients.
        Kidney Int. 1998; 54: 245-254
        • Kimmel P.L.
        • Peterson R.A.
        • Weihs K.L.
        • et al.
        Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
        J Am Soc Nephrol. 1996; 7: 2152-2159
        • Unruh M.L.
        • Weisbord S.D.
        • Kimmel P.L.
        Health-related quality of life in nephrology research and clinical practice.
        Semin Dial. 2005; 18: 82-90
        • Barrett B.J.
        • Vavasour H.M.
        • Major A.
        • et al.
        Clinical and psychological correlates of somatic symptoms in patients on dialysis.
        Nephron. 1990; 55: 10-15
        • Davison S.N.
        Pain in hemodialysis patients: Prevalence, cause, severity, and management.
        Am J Kidney Dis. 2003; 42: 1239-1247
        • Davison S.N.
        • Jhangri G.S.
        The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients.
        J Pain Symptom Manage. 2005; 30: 465-473
        • Davison S.N.
        • Jhangri G.S.
        • Johnson J.A.
        Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden.
        Kidney Int. 2006; 69: 1621-1625
        • Merkus M.P.
        • Jager K.J.
        • Dekker F.W.
        • et al.
        Physical symptoms and quality of life in patients on chronic dialysis: Results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD).
        Nephrol Dial Transplant. 1999; 14: 1163-1170
        • Parfrey P.S.
        • Vavasour H.
        • Bullock M.
        • et al.
        Symptoms in end-stage renal disease: Dialysis v transplantation.
        Transplant Proc. 1987; 19: 3407-3409
        • Parfrey P.S.
        • Vavasour H.
        • Bullock M.
        • et al.
        Development of a health questionnaire specific for end-stage renal disease.
        Nephron. 1989; 52: 20-28
        • Parfrey P.S.
        • Vavasour H.M.
        • Henry S.
        • et al.
        Clinical features and severity of nonspecific symptoms in dialysis patients.
        Nephron. 1988; 50: 121-128
        • Weisbord S.D.
        • Bruns F.J.
        • Rotondi A.J.
        • et al.
        Symptom burden, quality-of-life and advance care planning in highly comorbid hemodialysis patients: Is there a role for palliative care?.
        Nephrol Dial Transplant. 2003; 18: 1345-1352
        • Weisbord S.D.
        • Fried L.F.
        • Arnold R.M.
        • et al.
        Development of a symptom assessment instrument for chronic hemodialysis patients: The Dialysis Symptom Index.
        J Pain Symptom Manage. 2004; 27: 226-240
        • Weisbord S.D.
        • Fried L.F.
        • Arnold R.M.
        • et al.
        Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients.
        J Am Soc Nephrol. 2005; 16: 2487-2494
        • Kimmel P.L.
        • Emont S.L.
        • Newmann J.M.
        • et al.
        ESRD patient quality of life: Symptoms, spiritual beliefs, psychosocial factors, and ethnicity.
        Am J Kidney Dis. 2003; 42: 713-721
        • Wu A.W.
        • Fink N.E.
        • Cagney K.A.
        • et al.
        Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire.
        Am J Kidney Dis. 2001; 37: 11-21
        • Kimmel P.L.
        Just whose quality of life is it anyway?.
        Kidney Int. 2000; 57: S113-S120
        • Edgell E.T.
        • Coons S.J.
        • Carter W.B.
        • et al.
        A review of health-related quality-of-life measures used in end-stage renal disease.
        Clin Ther. 1996; 18: 887-938
        • Hays R.D.
        • Kallich J.D.
        • Mapes D.L.
        • et al.
        Development of the kidney disease quality of life (KDQOL) instrument.
        Qual Life Res. 1994; 3: 329-338
        • Evans R.W.
        • Rader B.
        • Manninen D.L.
        The quality of life of hemodialysis recipients treated with recombinant human erythropoietin.
        JAMA. 1990; 263: 825-830
        • Furuland H.
        • Linde T.
        • Ahlmen J.
        • et al.
        A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.
        Nephrol Dial Transplant. 2003; 18: 353-361
        • Levin N.W.
        • Lazarus J.M.
        • Nissenson A.R.
        National Cooperative rHu Erythropoietin Study in patients with chronic renal failure—An interim report.
        Am J Kidney Dis. 1993; 22: 3-12
        • Davison S.N.
        • Jhangri G.S.
        • Johnson J.A.
        Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients.
        Nephrol Dial Transplant. 2006; 21: 3189-3195
        • Binik Y.M.
        • Baker A.G.
        • Kalogeropoulos D.
        • et al.
        Pain, control over treatment, and compliance in dialysis and transplant patients.
        Kidney Int. 1982; 21: 840-848
        • Barakzoy A.S.
        • Moss A.H.
        Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease.
        J Am Soc Nephrol. 2006; 17: 3198-3203
        • Rosas S.E.
        • Joffe M.
        • Franklin E.
        • et al.
        Prevalence and determinants of erectile dysfunction in hemodialysis patients.
        Kidney Int. 2001; 59: 2259-2266
        • Seibel I.
        • Poli De Figueiredo C.E.
        • Teloken C.
        • et al.
        Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction.
        J Am Soc Nephrol. 2002; 13: 2770-2775
        • Hyodo T.
        • Ishida H.
        • Masui N.
        • et al.
        Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil.
        Ther Apher Dial. 2004; 8: 340-346
        • Kimmel P.L.
        Go to bed and get a good night’s sleep: You need your rest!.
        Am J Kidney Dis. 2000; 35: 1221-1223
        • Unruh M.L.
        • Hartunian M.G.
        • Chapman M.M.
        • et al.
        Sleep quality and clinical correlates in patients on maintenance dialysis.
        Clin Nephrol. 2003; 59: 280-288
        • Shayamsunder A.K.
        • Patel S.S.
        • Jain V.
        • et al.
        Sleepiness, sleeplessness, and pain in end-stage renal disease: Distressing symptoms for patients.
        Semin Dial. 2005; 18: 109-118
        • Millman R.P.
        • Kimmel P.L.
        • Shore E.T.
        • et al.
        Sleep apnea in hemodialysis patients: The lack of testosterone effect on its pathogenesis.
        Nephron. 1985; 40: 407-410
        • Walker S.
        • Fine A.
        • Kryger M.H.
        Sleep complaints are common in a dialysis unit.
        Am J Kidney Dis. 1995; 26: 751-756
        • Parker K.P.
        • Kutner N.G.
        • Bliwise D.L.
        • et al.
        Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis.
        Health Qual Life Outcomes. 2003; 1: 68
        • Iliescu E.A.
        • Coo H.
        • McMurray M.H.
        • et al.
        Quality of sleep and health-related quality of life in haemodialysis patients.
        Nephrol Dial Transplant. 2003; 18: 126-132
        • Shayamsunder A.K.
        • Khetpal P.
        • Patel S.S.
        • et al.
        Sleep disturbance, pain and quality of life in hemodialysis patients.
        J Am Soc Nephrol. 2004; 15 (abstr): 636A
        • Zoccali C.
        • Mallamaci F.
        • Tripepi G.
        Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients.
        J Am Soc Nephrol. 2002; 13: 729-733
        • Zeigler M.
        Sleep disorders and the failure to lower nocturnal blood pressure.
        Curr Opin Nephrol Hypertens. 2003; 12: 97-102
        • Jung H.H.
        • Han H.
        • Lee J.H.
        Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients.
        Am J Kidney Dis. 2005; 45: 875-882
        • Sivertsen B.
        • Omvik S.
        • Pallesen S.
        • et al.
        Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.
        JAMA. 2006; 295: 2851-2858
        • Pressman M.R.
        • Benz R.L.
        • Schleifer C.R.
        • et al.
        Sleep disordered breathing in ESRD: Acute beneficial effects of treatment with nasal continuous positive airway pressure.
        Kidney Int. 1993; 43: 1134-1139
        • Janzen L.
        • Rich J.A.
        • Vercaigne L.M.
        An overview of levodopa in the management of restless legs syndrome in a dialysis population: Pharmacokinetics, clinical trials, and complications of therapy.
        Ann Pharmacother. 1999; 33: 86-92
        • Juergense P.H.
        • Botev R.
        • Wuerth D.
        • et al.
        Erectile dysfunction in chronic peritoneal dialysis patients: Incidence and treatment with sildenafil.
        Perit Dial Int. 2001; 21: 355-359
        • Turk S.
        • Karalezli G.
        • Tonbul H.Z.
        • et al.
        Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
        Nephrol Dial Transplant. 2001; 16: 1818-1822
        • Rocco M.V.
        • Gassman J.J.
        • Wang S.R.
        • et al.
        Cross-sectional study of quality of life and symptoms in chronic renal disease patients: The Modification of Diet in Renal Disease Study.
        Am J Kidney Dis. 1997; 29: 888-896
        • Saini T.
        • Murtagh F.E.
        • Dupont P.J.
        • et al.
        Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease.
        Palliat Med. 2006; 20: 631-636